Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 16, 2022 20:30 ET | Source: The Rosen Law Firm PA

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – PLSE

NEW YORK, March 16, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Pulse Biosciences, Inc. (NASDAQ: PLSE) between January...
March 08, 2022 09:30 ET | Source: Inspirata, Inc.

Inspirata Receives Industry’s First FDA Clearance for Scanner Agnostic Digital Pathology Software

Tampa, Florida, March 08, 2022 (GLOBE NEWSWIRE) -- Digital pathology and cancer informatics provider Inspirata announced today that it has received U.S. Food and Drug Administration (FDA) clearance...
October 18, 2021 17:07 ET | Source: The Rosen Law Firm PA

NNOX SHAREHOLDER ALERT: ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Nano-X Imaging Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – NNOX

NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Nano-X Imaging Ltd. (NASDAQ: NNOX) between June 17,...
October 07, 2021 16:37 ET | Source: The Rosen Law Firm PA

ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – NNOX

NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Nano-X...
January 21, 2021 15:58 ET | Source: Inspirata, Inc.

Proposed FDA Regulatory Flexibilities Permit Primary Diagnosis with Inspirata’s Dynamyx Digital Pathology Solution

Tampa, Florida, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that pandemic-related regulatory flexibilities issued by the U.S....
January 05, 2021 08:00 ET | Source: biotricity

Biotricity Submitted 510(k) U.S. FDA Filing for Biotres

REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it made a...
September 01, 2020 08:00 ET | Source: biotricity

Biotricity Provides Quarter Update and Announces Continued Growth

REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced record results in its...
August 04, 2020 08:00 ET | Source: biotricity

Biotricity Receives FDA clearance for Bioflux Software II System

REDWOOD CITY, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has received a 510(k)...
June 23, 2020 11:38 ET | Source: Northeast Scientific, Inc.

Northeast Scientific Inc. Wins 510(k) for IVUS Catheter Reprocessing

WATERBURY, Conn., June 23, 2020 (GLOBE NEWSWIRE) -- Northeast Scientific Inc., this week announced it has received FDA clearance for reprocessing the .014 Digital IVUS catheter. This is the second...
February 13, 2020 08:00 ET | Source: biotricity

Biotricity Files a 510(k) Application for its Advanced ECG Analysis Software

REDWOOD CITY, Calif., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has filed a 510(k)...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right